PNC Financial Services Group’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.9K | Buy |
820
+713
| +666% | +$9.52K | ﹤0.01% | 3832 |
|
|
2025
Q1 | $1.09K | Buy |
+107
| New | +$1.09K | ﹤0.01% | 4503 |
|
|
2024
Q4 | – | Sell |
-4
| Closed | -$232 | – | 4870 |
|
|
2024
Q3 | $232 | Hold |
4
| – | – | ﹤0.01% | 4666 |
|
|
2024
Q2 | $183 | Sell |
4
-21
| -84% | -$961 | ﹤0.01% | 4678 |
|
|
2024
Q1 | $1.66K | Buy |
25
+3
| +14% | +$199 | ﹤0.01% | 4249 |
|
|
2023
Q4 | $875 | Buy |
+22
| New | +$875 | ﹤0.01% | 4338 |
|